Clinical Cancer Research · 2009 · 212 citations · 20 references
Life SciencesGeneticsOncologyCancer GeneticsMetastasisTumor ProgressionCancer EpigeneticsCancer EpigenomicsEpigenetic Alterations In CancerEpigenetic Regulation In CancerMalignant NeoplasmsTumor Suppressor GenesCpg Island Aberrant MethylationCpg Island HypermethylationCpg Island Methylation PatternsCpg Island Promoter MethylationMelanoma ProgressionTumor Suppressor Gene HypermethylationTumor Suppressor Gene MethylationTumor Suppressor Loss
PURPOSE: The CpG island methylator phenotype (CIMP) may be associated with development of malignancy through coordinated inactivation of tumor suppressor and tumor-related genes (TRG) and methylation of multiple noncoding, methylated-in-tumor (MINT) loci. These epigenetic changes create a distinct CIMP pattern that has been linked to recurrence and survival in gastrointestinal cancers. Because epigenetic inactivation of TRGs also has been shown in malignant melanoma, we hypothesized the existence of a clinically significant CIMP in cutaneous melanoma progression. EXPERIMENTAL DESIGN: The methylation status of the CpG island promoter region of TRGs related to melanoma pathophysiology (WIF1, TFPI2, RASSF1A, RARbeta2, SOCS1, and GATA4) and a panel of MINT loci (MINT1, MINT2, MINT3, MINT12, MINT17, MINT25, and MINT31) in primary and metastatic tumors of different clinical stages (n=122) was assessed. RESULTS: Here, we show an increase in hypermethylation of the TRGs WIF1, TFPI2, RASSF1A, and SOCS1 with advancing clinical tumor stage. Furthermore, we find a significant positive association between the methylation status of MINT17, MINT31, and TRGs. The methylation status of MINT31 is associated with disease outcome in stage III melanoma. CONCLUSIONS: These findings show the significance of a CIMP pattern that is associated with advancing clinical stage of malignant melanoma. Future prospective large-scale studies may determine if CIMP-positive primary melanomas are at high risk of metastasis or recurrence.
20
Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2007 · 7.5K citations · Full text
MethPrimer: designing primers for methylation PCRs
Long-Cheng Li, Rajvir Dahiya · Bioinformatics · 2002 · 2.8K citations · Full text
CpG island methylator phenotype in colorectal cancer
Minoru Toyota, Nita Ahuja, Mutsumi Ohe-Toyota et al. · Proceedings of the National Academy of Sciences · 1999 · 2.5K citations
Wnt Inhibitory Factor-1 Is Silenced by Promoter Hypermethylation in Human Lung Cancer
Julien Mazières, Biao He, Liang You et al. · Cancer Research · 2004 · 271 citations · Full text